학술논문
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors.
Document Type
Article
Author
Zattarin, Emma; Mariani, Luigi; Menichetti, Alice; Leporati, Rita; Provenzano, Leonardo; Ligorio, Francesca; Fucà, Giovanni; Lobefaro, Riccardo; Lalli, Luca; Vingiani, Andrea; Nichetti, Federico; Griguolo, Gaia; Sirico, Marianna; Bernocchi, Ottavia; Marra, Antonio; Corti, Chiara; Zagami, Paola; Agostinetto, Elisa; Jacobs, Flavia; Di Mauro, Pierluigi
Source
Therapeutic Advances in Medical Oncology; 12/20/2023, p1-17, 17p
Subject
Language
ISSN
17588340
Abstract
Copyright of Therapeutic Advances in Medical Oncology is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)